UA90504C2 - Лекарственное средство для лечения заболеваний дыхательных путей - Google Patents

Лекарственное средство для лечения заболеваний дыхательных путей

Info

Publication number
UA90504C2
UA90504C2 UAA200710494A UAA200710494A UA90504C2 UA 90504 C2 UA90504 C2 UA 90504C2 UA A200710494 A UAA200710494 A UA A200710494A UA A200710494 A UAA200710494 A UA A200710494A UA 90504 C2 UA90504 C2 UA 90504C2
Authority
UA
Ukraine
Prior art keywords
respiratory diseases
treating respiratory
novel drugs
compounds
producing
Prior art date
Application number
UAA200710494A
Other languages
English (en)
Ukrainian (uk)
Inventor
Инга Конетцки
Тьери Буиси
Филипп Лустенбергер
Андреас Шнапп
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of UA90504C2 publication Critical patent/UA90504C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

В заявке описано применение соединений общей формулы (1), (1)в которой остатки R, Rи Rмогут иметь указанные в формуле изобретения и в описании значения,для приготовления лекарственного средства, предназначенного для лечения заболеваний дыхательных путей, а также описаны новые соединения формулы 1, способ их получения и фармацевтические композиции, которые их содержат.
UAA200710494A 2005-02-24 2006-02-16 Лекарственное средство для лечения заболеваний дыхательных путей UA90504C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005008921A DE102005008921A1 (de) 2005-02-24 2005-02-24 Neue Arzneimittel zur Behandlung von Atemwegserkrankungen

Publications (1)

Publication Number Publication Date
UA90504C2 true UA90504C2 (ru) 2010-05-11

Family

ID=36179764

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200710494A UA90504C2 (ru) 2005-02-24 2006-02-16 Лекарственное средство для лечения заболеваний дыхательных путей

Country Status (26)

Country Link
US (3) US20060189605A1 (ru)
EP (1) EP1856070B1 (ru)
JP (1) JP4950075B2 (ru)
KR (1) KR20070110386A (ru)
CN (1) CN101128444A (ru)
AR (1) AR055562A1 (ru)
AT (1) ATE517877T1 (ru)
AU (1) AU2006218010B2 (ru)
BR (1) BRPI0607258A2 (ru)
CA (1) CA2598914A1 (ru)
DE (1) DE102005008921A1 (ru)
DK (1) DK1856070T3 (ru)
EA (1) EA012439B1 (ru)
ES (1) ES2370653T3 (ru)
IL (1) IL185444A0 (ru)
MX (1) MX2007010363A (ru)
MY (1) MY146802A (ru)
NO (1) NO20073176L (ru)
NZ (1) NZ561743A (ru)
PE (1) PE20061097A1 (ru)
PL (1) PL1856070T3 (ru)
TW (1) TWI369988B (ru)
UA (1) UA90504C2 (ru)
UY (1) UY29394A1 (ru)
WO (1) WO2006089859A1 (ru)
ZA (1) ZA200704727B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005008921A1 (de) * 2005-02-24 2006-08-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
US7423146B2 (en) * 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
PE20080610A1 (es) 2006-08-22 2008-07-15 Boehringer Ingelheim Int Nuevos beta-agonistas enantiomericamente puros, procedimientos para su preparacion y uso como medicamentos
JP2010501520A (ja) * 2006-08-22 2010-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 光学異性的に純粋なベータ作動薬を含む吸入用粉末製剤
PE20080425A1 (es) * 2006-08-22 2008-06-16 Boehringer Ingelheim Int Formulacion aerosol para la inhalacion de beta-agonistas
UY30552A1 (es) * 2006-08-22 2008-03-31 Boehringer Ingelheim Int Combinaciones farmacologiicas en base a derivados sustituidos de la n-(5-{2-[1,1-dimetil-propilamino]-1-hidroxi-metil}-2-hidroxi-fenil)-metansulfonamida y aplicaciones
EP2093219A1 (de) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
GB201217330D0 (en) * 2012-09-28 2012-11-14 Univ Cardiff Therapeutic for treating inflammatory lung disorders
AU2015370463B2 (en) * 2014-12-24 2020-12-24 Kither Biotech S.R.L. Novel PI3K gamma inhibitor peptide for treatment of respiratory system diseases

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3026534A1 (de) * 1980-07-12 1982-03-18 C.H. Boehringer Sohn, 6507 Ingelheim 3,1-benzoxazin-2-one, ihre herstellung und verwendung
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
US4570630A (en) * 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
DE3609152A1 (de) * 1986-03-19 1987-09-24 Bayer Ag Verfahren zur herstellung des (-)-antipoden des (e)-1-cyclohexyl-4,4-dimethyl- 3-hydroxy-2-(1,2,4-triazol-1-yl)-pent-1-ens
JP4516064B2 (ja) * 2003-04-04 2010-08-04 ノバルティス アーゲー 気道疾患の処置のためのキノリン−２−オン誘導体
DE102004003428A1 (de) * 2004-01-23 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel
US7220742B2 (en) * 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102005008921A1 (de) * 2005-02-24 2006-08-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
US7423146B2 (en) * 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
PE20080425A1 (es) * 2006-08-22 2008-06-16 Boehringer Ingelheim Int Formulacion aerosol para la inhalacion de beta-agonistas
UY30552A1 (es) * 2006-08-22 2008-03-31 Boehringer Ingelheim Int Combinaciones farmacologiicas en base a derivados sustituidos de la n-(5-{2-[1,1-dimetil-propilamino]-1-hidroxi-metil}-2-hidroxi-fenil)-metansulfonamida y aplicaciones

Also Published As

Publication number Publication date
UY29394A1 (es) 2006-10-02
PE20061097A1 (es) 2006-11-14
WO2006089859A1 (de) 2006-08-31
ZA200704727B (en) 2008-09-25
EA200701615A1 (ru) 2008-02-28
AU2006218010A1 (en) 2006-08-31
TWI369988B (en) 2012-08-11
DK1856070T3 (da) 2011-09-26
TW200640465A (en) 2006-12-01
JP4950075B2 (ja) 2012-06-13
US20090105236A1 (en) 2009-04-23
EP1856070B1 (de) 2011-07-27
EP1856070A1 (de) 2007-11-21
CA2598914A1 (en) 2006-08-31
EA012439B1 (ru) 2009-10-30
PL1856070T3 (pl) 2011-12-30
ES2370653T3 (es) 2011-12-21
ATE517877T1 (de) 2011-08-15
NZ561743A (en) 2009-09-25
AU2006218010B2 (en) 2013-02-14
NO20073176L (no) 2007-09-17
US20060189605A1 (en) 2006-08-24
MX2007010363A (es) 2007-09-25
BRPI0607258A2 (pt) 2009-08-25
MY146802A (en) 2012-09-28
CN101128444A (zh) 2008-02-20
DE102005008921A1 (de) 2006-08-31
AR055562A1 (es) 2007-08-22
US20110053926A1 (en) 2011-03-03
KR20070110386A (ko) 2007-11-16
JP2008531518A (ja) 2008-08-14
IL185444A0 (en) 2008-01-06

Similar Documents

Publication Publication Date Title
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
UA86977C2 (ru) Производные гидантоина для лечения обструктивных болезней дыхательных путей
UA90504C2 (ru) Лекарственное средство для лечения заболеваний дыхательных путей
MX2007003031A (es) Compuestos heteroarilo para uso como betamimeticos en el tratamiento de enfermedades de vias respiratorias.
SE0200920D0 (sv) Novel compounds
TW200508214A (en) Novel compounds
UA89787C2 (ru) Фторгликозидные производные пиразолов, лекарственное средство, которое содержит их, и их применение
SE0104140D0 (sv) Novel Compounds
SE0202539D0 (sv) Compounds
GEP20115231B (en) 2-amino-7,8-dihydro-6h-pyrido [4,3-d] pyrimidin-5-ones
EA200601837A1 (ru) Бензоксазины для лечения заболеваний дыхательных путей
TW200503674A (en) Therapeutic agents
PL1758852T3 (pl) Podstawione związki cyklopentenu
TW200738659A (en) Novel compounds
TW200639156A (en) New compounds
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
UA83691C2 (ru) Применение замещенных 2-аминотетралинов для упреждающего лечения болезни паркинсона
PL1727817T3 (pl) Pochodne azabicyklooktan-3-onu i ich zastosowanie
IL183636A0 (en) Quinoline derivative, use and production thereof, and drug containing the same
MXPA05010020A (es) Derivados de oxamida.
GB2446341A (en) Method and system for transdermal drug delivery
TW200634002A (en) Chemical compounds
IL166057A0 (en) Urea-substituted and urethane-substituted acylureas methods for the production thereof and their useas medicaments
TW200716618A (en) Chemical compounds